Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glucose Control”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02467920
What this trial is testing

Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM

Who this might be right for
Type 2 Diabetes Mellitus
Huazhong University of Science and Technology 349
Post-approval studies (Phase 4)Study completedNCT01175824
What this trial is testing

Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 478
Large-scale testing (Phase 3)Study completedNCT01434186
What this trial is testing

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 32
Large-scale testing (Phase 3)Study completedNCT01242202
What this trial is testing

Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 113
Large-scale testing (Phase 3)Study completedNCT02096705
What this trial is testing

Phase III Insulin Add-On Asia Regional Program - ST

Who this might be right for
Diabetes
AstraZeneca 477
Large-scale testing (Phase 3)Not Yet RecruitingNCT06731075
What this trial is testing

Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Type 2 Diabetes Mellitus
Oramed, Ltd. 300
Large-scale testing (Phase 3)Study completedNCT00147719
What this trial is testing

WelChol® With Metformin in Treating Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Daiichi Sankyo 300
Early research (Phase 1)UnknownNCT02366351
What this trial is testing

The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 Diabetes Mellitus
Jiangsu HengRui Medicine Co., Ltd. 168
Large-scale testing (Phase 3)Study completedNCT02068443
What this trial is testing

Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 374
Post-approval studies (Phase 4)Study completedNCT02157298
What this trial is testing

Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin.

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 266
Large-scale testing (Phase 3)Study completedNCT01717313
What this trial is testing

Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 329
Testing effectiveness (Phase 2)Study completedNCT02113332
What this trial is testing

Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections

Who this might be right for
Type 2 Diabetes Mellitus
Vastra Gotaland Region 124
Testing effectiveness (Phase 2)Study completedNCT01117584
What this trial is testing

Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 343
Large-scale testing (Phase 3)Study completedNCT01590797
What this trial is testing

A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 467
Large-scale testing (Phase 3)Study completedNCT03242252
What this trial is testing

Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease Stage 3
Lexicon Pharmaceuticals 787
Large-scale testing (Phase 3)Study completedNCT00295633
What this trial is testing

A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 565
Testing effectiveness (Phase 2)Study completedNCT01405911
What this trial is testing

Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105)

Who this might be right for
Glucose Intolerance
Merck Sharp & Dohme LLC 242
Large-scale testing (Phase 3)Study completedNCT00736879
What this trial is testing

Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 497
Large-scale testing (Phase 3)Study completedNCT02452632
What this trial is testing

Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Korea, Inc. 143
Large-scale testing (Phase 3)Study completedNCT05814393
What this trial is testing

To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
JW Pharmaceutical 200
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation